Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: HAE stock price vs LLY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LLY's multiple
Needs LLY P/E.
Implied fair value · at HAE's multiple
Needs HAE P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: HAE FY 2026 (ended Mar 28, 2026) · LLY FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Haemonetics Corporation · implied price per share
Bear
$17.66
Base
$20.78
Bull
$23.89
ELI LILLY AND COMPANY · implied price per share
Bear
$191.97
Base
$225.85
Bull
$259.72
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.56x
1.60x
Net debt / EBITDA
Leverage against operating earnings
3.75x
1.22x
Cash and equivalents
Liquid reserves on the balance sheet
$245.44M
$7.42B
Total debt
Interest-bearing obligations outstanding
$1.24B
$42.50B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BECTON DICKINSON & CO
HAE vs BDX
BAXTER INTERNATIONAL INC
HAE vs BAX
LivaNova PLC
HAE vs LIVN
STERIS plc
HAE vs STE
Pfizer Inc.
HAE vs PFE
Merck & Co., Inc.
HAE vs MRK
Johnson & Johnson
HAE vs JNJ
AbbVie Inc.
HAE vs ABBV
Amgen Inc.
HAE vs AMGN
Bristol-Myers Squibb Company
HAE vs BMY
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
